EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer

Sebastian Curcean iD, Alexandra Gherman iD, Alexandru Tipcu iD, Zsolt Fekete iD, Alina-Simona Muntean, Andra Curcean iD, Rares Craciun iD, Stefan Stanciu, Alexandru Irimie

Medicina · 2024

DOI: 10.3390/medicina60101606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Sebastian Curcean und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Sarcopenia, Rectal Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Sarcopenia, a condition characterized by muscle mass loss, is prevalent in up to 68% of rectal cancer patients and has been described as a negative prognostic factor, impacting overall survival and tumor response. While there are extensive data on rectal cancer globally, only a handful of studies have evaluated the role of sarcopenia in locally advanced rectal cancer (LARC). Our study aimed to investigate the relationship between sarcopenia, overall response rate, and toxicity in patients who underwent total neoadjuvant treatment (TNT) for LARC. Materials and Methods: We performed a retrospective study of patients with rectal cancer treated with TNT and surgery with curative intent between 2021 and 2023 at Prof. Dr. Ion Chiricuta Institute of Oncology, Cluj-Napoca. Sarcopenia was assessed on MRI images by measuring the psoas muscle area (PMA) at the level of the L4 vertebra before and after neoadjuvant therapy. The primary endpoints were the overall complete response rate (oCR) and acute toxicity.

Results

This study included 50 patients with LARC. The oCR rate was 18% and was significantly associated with post-treatment sarcopenia (OR 0.08, p = 0.043). Patients who did not achieve a clinical or pathologic complete response had, on average, an 8% muscle loss during neoadjuvant therapy (p = 0.022). Cystitis and thrombocytopenia were significantly associated with post-treatment sarcopenia (p = 0.05 and p = 0.049).

Conclusions

Sarcopenia and loss of psoas muscle during neoadjuvant therapy were negatively associated with tumor response in locally advanced rectal cancer. Thrombocytopenia and cystitis are more frequent in sarcopenic than non-sarcopenic patients undergoing neoadjuvant chemoradiation for rectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaRectal NeoplasmsNeoadjuvant TherapyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeAdultMagnetic Resonance ImagingPsoas MusclesAged, 80 and over

Stichwörter der Autor:innen

clinical complete responselocally advanced rectal cancerpathological complete responsesarcopeniatoxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
  • Department of Radiation Oncology, "Prof. Dr. Ion Chiricuta" Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
  • Department of Medical Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
  • Department of Medical Oncology, "Prof. Dr. Ion Chiricuta" Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
  • Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
  • Department of Imaging, Affidea Center, 15c Ciresilor Street, 400487 Cluj-Napoca, Romania.

ORCID-Profile: Sebastian Curcean, Alexandra Gherman, Alexandru Tipcu, Zsolt Fekete, Andra Curcean, Rares Craciun

Zitieren

APA

Curcean, S., Gherman, A., Tipcu, A., Fekete, Z., Muntean, A. S., Curcean, A., Craciun, R., Stanciu, S., & Irimie, A. (2024). Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer. Medicina. https://doi.org/10.3390/medicina60101606

Vancouver

Curcean S, Gherman A, Tipcu A, Fekete Z, Muntean AS, Curcean A, et al. Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer. Medicina. 2024. doi:10.3390/medicina60101606

BibTeX
@article{Curcean2024,
  author = {Curcean, Sebastian and Gherman, Alexandra and Tipcu, Alexandru and Fekete, Zsolt and Muntean, Alina-Simona and Curcean, Andra and Craciun, Rares and Stanciu, Stefan and Irimie, Alexandru},
  title = {Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60101606}
}
Kostenlos starten →